Verified peer comparison
Aytu BioPharma vs Exagen Financial Comparison
Direct answer
Aytu BioPharma and Exagen are compared on the same basis.
The comparison uses 2025 results reported in USD.
Common metrics include Revenue, Operating income, Net income, Operating cash flow.
Alpha Vantage
Get free Aytu BioPharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Aytu BioPharma Revenue
- 66,382,000 USD
- Exagen Revenue
- 66,575,000 USD
- Aytu BioPharma Operating income
- -7,827,000 USD
- Exagen Operating income
- -14,070,000 USD